(Q37051027)

17 August 2017

1 reference

title

TLR signaling by tumor and immune cells: a double-edged sword (English)

1 reference

17 August 2017

0 references

B Huang

1

1 reference

17 August 2017

J Zhao

2

1 reference

17 August 2017

J C Unkeless

3

1 reference

17 August 2017

Z H Feng

4

1 reference

17 August 2017

H Xiong

5

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

17 August 2017

1 reference

17 August 2017

volume

27

1 reference

17 August 2017

issue

2

1 reference

17 August 2017

page(s)

218-224

1 reference

Pattern of expression of beta-defensins in oral squamous cell carcinoma.

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Pathogen recognition and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Toll-like receptors mediate proliferation and survival of multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Toll-like receptor 4 genetic variation and advanced prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

The TLR7 agonist imiquimod enhances the anti-melanoma effects of a recombinant Listeria monocytogenes vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Phosphatidylinositol-3-OH kinase/AKT and survivin pathways as critical targets for geranylgeranyltransferase I inhibitor-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Nucleic acid-sensing TLRs as modifiers of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Human lung cancer cells express functionally active Toll-like receptor 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Masquerader: high mobility group box-1 and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Intracellular expression of toll-like receptor 4 in neuroblastoma cells and their unresponsiveness to lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

A Toll-like receptor recognizes bacterial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Toll-like receptors on tumor cells facilitate evasion of immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Toll-like receptor control of the adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Expression and function of Toll-like receptors in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

mRNA is an endogenous ligand for Toll-like receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Pathogen recognition with Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Development of TLR9 agonists for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Increased toll-like receptor 9 expression in cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Transforming growth factor-beta regulation of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Inhibition of hepatocarcinoma and tumor metastasis to liver by gene therapy with recombinant CBD-HepII polypeptide of fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Toll-like receptors in systemic autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Indoleamine 2,3-dioxygenase and tumor-induced tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

The extra domain A of fibronectin activates Toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

How Toll-like receptors signal: what we know and what we don't know

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Toll-like receptors, endogenous ligands, and systemic autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

HLA-G in cancer: a way to turn off the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumor growth and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Innate sensing of self and non-self RNAs by Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Toll-like receptor 2 controls expansion and function of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

21 January 2018

TLR signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Endogenous ligands of Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Pathogen-associated molecular pattern contamination as putative endogenous ligands of Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Tumour escape from immune surveillance through dendritic cell inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Regulatory T cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Endotoxin/lipopolysaccharide activates NF-kappa B and enhances tumor cell adhesion and invasion through a beta 1 integrin-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Role of heat shock proteins in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Sequence variants in toll-like receptor 10 are associated with nasopharyngeal carcinoma risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

Sequence Variants of Toll-Like Receptor 4 and Susceptibility to Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

7 January 2021

Expression of p63, keratin 5/6, keratin 7, and surfactant-A in non-small cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

7 January 2021

Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

7 January 2021

Comparative characterization of pulmonary surfactant aggregates and alkaline phosphatase isozymes in human lung carcinoma tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

7 January 2021

Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

7 January 2021

Mechanism of anticancer host response induced by OK-432, a streptococcal preparation, mediated by phagocytosis and Toll-like receptor 4 signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

7 January 2021

Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

7 January 2021

Phase II trial of a toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

7 January 2021

Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

7 January 2021

Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

7 January 2021

Functional variant in the 3'-untranslated region of Toll-like receptor 4 is associated with nasopharyngeal carcinoma risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

7 January 2021

Sequence Variants in Toll-Like Receptor Gene Cluster (TLR6-TLR1-TLR10) and Prostate Cancer Risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

7 January 2021

Assessment of expression of toll-like receptors 2, 3 and 4 in laryngeal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210904

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210904

1 reference

17 August 2017

1 reference